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[57] ABSTRACT 
A method for specifying a fatty acid at the sn2 position of 
acylglycerol lipids including (a) transfecting a vector includ 
ing the SLC1 gene or a variant thereof into embryonic 
biological material, and (b) alloWing the SLC1 gene to 
specify the type of fatty acid at the sn2 position of acylg 
lycerol lipids. Also provided for is an isolated SLC1 gene 
and a probe for its detection. 
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TECHNIQUE FOR SPECIFYING THE FATTY 
ACID AT THE SN2 POSITION OF 
ACYLGLYCEROL LIPIDS 
TECHNICAL FIELD 
The present invention is directed to a technique for 
specifying the fatty acid at the sn2 position of acylglycerol 
lipids in biological material. Also provided is an isolated 
SLC1 gene and a probe for its detection. 
BACKGROUND 
All membranes of living cells contain glycerophospho 
lipids Which have fatty acid attached to the 1 and 2 carbons 
of the 3-carbon glycerol molecule. The fatty acids at these 
tWo positions have different numbers of carbon atoms and 
degrees of unsaturation (a double bond betWeen the tWo 
carbon atoms). The length of the fatty acid and degree of 
saturation have important dietary consequences for man. For 
example, diets rich in saturated fatty acids are associated 
With increased risk of coronary artery disease Whereas 
monounsaturated fatty acids are associated With decreased 
risk. Plant seed also consist largely of triacylglycerol 
glycerol having three fatty acids. 
The type of fatty acids present in glycerolipids is deter 
mined by enZymes called fatty acyltransferases. The present 
inventors isolate the ?rst eucaryotic gene, SLC1 that 
encodes a transferase speci?c for the 2 position of glycero 
lipids from Saccharomyces cerevisiae. 
Determining the biological function(s) and mode of action 
of individual sphingolipids in multicellular eucaryotes has 
proven to be a challenging and un?nished task because of 
the great variety of sphingolipids present in such organisms 
(1—3, see reference citations beloW). In contrast to this 
variety, the unicellular eucaryote Saccharomyces cerevisiae 
has only one major and tWo minor types of structurally 
related sphingolipids. Such simplicity provides a unique 
opportunity to study sphingolipid function(s) in an organism 
to Which molecular genetic techniques can be readily 
applied. 
The most abundant sphingolipid in S. cerevisiae is man 
nosyldiinositolphosphorylceramide With lesser amounts of 
inositolphosphorylceramide and mannosylinositolphospho 
rylceramide (4,5). The ceramide moiety contains the sphin 
goid long chain base phytosphingosine linked by an amide 
bond to a C26 fatty acid 
Synthesis of phytosphingosine initiates With the conden 
sation of serine and palmitoyl-CoA catalyZed by serine 
palmitoyltransferase to yield 3-ketodihydrosphingosine In S. cerevisiae the nZym  or on  f its subunits is encoded 
by the LCB1 gene Strains defective in lcb1 lack serine 
palmitoyltransferase activity and have an Lcb‘ phenotype 
because they require a long chain base such as phytosphin 
gosine for groWth (8—10). The Lcb' phenotype provides a 
starting point for a molecular genetic analysis of sphin 
golipid function(s). Saccharomyces cerevisiae normally 
requires sphingolipid biosynthesis for groWth. 
Some glycerolipids of Saccharomyces cerevisiae are 
knoWn. For example, US. Pat. No. 5,057,419 is entitled 
Genetically Engineered Plasmid and Organisms for the 
production of SpecialiZed Oils. This patent discloses an 
expression vector encoding a yeast delta-9 fatty acid desatu 
rase enZyme Which functions in a yeast cell to induce or 
enhance oil production. The overproduction of delta-9 
desaturase by the cells leads to the production of abnormally 
high levels of unsaturated fatty acids in the cell membrane. 
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In order to compensate for the increased levels of unsatur 
ated fatty acids in the lipids, excess unsaturated fatty acids 
are removed from the membrane lipids and shunted into 
triglyceride formation. The yeast are indicated to overpro 
duce oils containing polyunsaturated fatty acid With superior 
properties. 
US. Pat. No. 5,288,619 to Moore discloses a process for 
industrial enZymatic interesteri?cation of a triglyceride 
including steps of reacting a triglyceride in an enZyme 
conversion Zone. The enZymes Which are used are preferably 
1,3 speci?c lipases. 
US. Pat. No. 5,286,633 to BroWn et al. discloses an 
enZymatic transesteri?cation method for preparing a mar 
garine oil. The margarine oil product has a non-random fatty 
acid distribution in Which esteri?ed stearic acid is predomi 
nantly distributed in the 1,3-positions While esteri?ed unsat 
urated fatty acid moieties are in higher concentration in the 
2- position of the glycerides. The method of making the 
margarine oil includes a step of providing a transesteri?ca 
tion reaction mixture comprising stearic acid and triglycer 
ide vegetable oil and transesterifying using a 1,3 lipase. 
EnZymes from synthetic sources are contemplated, includ 
ing yeasts. 
Chemical Abstracts, Vol. 92, Abstract 17761W, (1980) 
“Characterization of sterol ester synthetase in Saccharomy 
ces cerevisiae” discloses that cell free extracts of Saccha 
romyces cerevisiae catalyZed the synthesis of fatty acid ester 
of sterol from cholesterol, fatty acid, ATP, and CoA or from 
cholesterol and fatty acyl CoA. The enZyme involved in the 
formation of the ester is acyl-CoA-sterol-O-acyltransferase. 
Chemical Abstracts, Vol. 91, Abstract 188621j, (1979) 
“Utilization of endogenous diacyl glycerol for the synthesis 
of triacylglycerol, phosphatidylcholine and phosphatidyl 
ethanolamine by lipid particles from baker’s yeast” discloses 
a measurement of the activity of 3 enZymes prepared from 
S. cerevisiae in the presence of 1,2-diacylglycerol substrates. 
The enZymes include diacylglycerol acyltransferase, choline 
phosphotransferase, and ethanolamine phosphotransferase. 
Chemical Abstracts, Vol. 88, Abstract 165910b, (1978), 
“Glycerolipid biosynthesis in Saccharomyces Cerevisiae” 
discloses an investigation of S. cerevisiae dihydroxyacetone 
phosphate acyltransferase to determine Whether its activity 
and that of glycerol phosphate acyltransferase represent dual 
catalytic functions of a single membranous enZyme. 
Chemical Abstracts, Vol. 87, Abstract 129342p, (1977), 
“Acyltransferase systems involved in phospholipid metabo 
lism in Saccharomyces cerevisiae” discloses membrane 
preparations of S. cerevisiae catalyZed the acylation of 
glycerophosphate, 1 acyl- and 2 acyl-glycerophosphates and 
1 acyl- and 2 acyl-glycerylphosphocholines. Speci?city of 
glycerophosphate acyltransferase, 2-acylglycerophosphate 
acyltransferase and 1-acylglycerophosphate acyltransferase 
Were determined. 
Chemical Abstracts, Vol. 105, Abstract 94333x, (1986), 
“Mutants of Saccharomyces cerevisiae defective in 
sn-glycerol-3-phosphate acyltransferase: Simultaneous loss 
of dihydroxy acetone phosphate acyltransferase indicates a 
common gene” discloses the isolation of fourteen indepen 
dent mutants defective in sn-glycerol-3-phosphate acyltrans 
ferase activity. 
Chemical Abstracts, Vol. 115, Abstract 274626k, (1991), 
“Acyl CoA-cholesterol acyltransferase (ACAT) inhibitors 
from microbial and plant lipids” discloses that enZyme 
ACAT, responsible for absorption of cholesterol by the 
intestinal epithelium is inhibited by fatty acid-like sub 
stances obtained from enZymatic degradation products of 
microbial and plant products. 
5,869,304 
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Chemical Abstracts, Vol. 114, Abstract 38917q, (1991), is 
directed to “Genetic and biochemical studies of sn-glycerol 
3-phosphate acyltransferase in Saccharomyces cerevisiae”. 
Chemical Abstracts, Vol. 117, Abstract 167433q, (1992), 
“The acyl dihydroXyacetone phosphate pathWay enZymes 
for glycerolipid biosynthesis are present in the yeast Sac 
charomyces cerevisiae” discloses studies of the acyl dihy 
droXyacetone phosphate pathWay enZymes for glycerolipid 
biosynthesis. This pathWay is used in yeast Saccharomyces 
cerevisiae non-ether glycerolipid synthesis. 
There is a need in the art for a knowledge of the SLC1 
gene of Saccharomyces cerevisiae and its use to construct 
economically and dietetically important plants, such as 
seeds, from Which cooking oils are obtained Which have 
fatty acids With optimal bene?ts, as Well as better storage 
properties. Likewise, there is a need to produce animals 
Whose meat products Would contain glycerolipids With fatty 
acids having different degrees of saturation and/or chain 
length. Such changes improve the ?avor and storage prop 
erties and reduce adverse effects on humans, for example, by 
reducing the percentage of polyunsaturated fatty acids. The 
present invention provides these bene?ts and overcomes the 
de?ciencies and lack of knoWledge of the prior art. 
DISCLOSURE OF THE INVENTION 
An object of the present invention is to provide a tech 
nique for specifying the fatty acid at the sn2 position of 
acylglycerol lipids. 
The method for specifying a fatty acid at the sn2 position 
of acylglycerol lipids includes (a) transfecting a vector 
including the SLC1 gene or a variant thereof into embryonic 
biological material, and (b) alloWing the SLC1 gene to 
replicate to direct fatty acid at the sn2 position of acylglyc 
erol lipids. The biological material may be plant or animal 
embryonic material. 
The invention provides for isolation and characteriZation 
of the SLC1 gene of Saccharomyces cerevisiae. Also pro 
vided for is an isolated SLC1 gene and a probe for its 
detection. 
In an alternative embodiment, the invention provides for 
use of the SLC1 gene of Saccharomyces cerevisiae as a 
probe for isolation of homologous gene sequences in other 
organisms. The probe may be labeled by methods knoWn in 
the art. 
The invention provides for use of the SLC1 gene to 
construct economically and dietetically important plants, 
such as seeds from Which cooking oils are obtained Which 
have fatty acids With optimal bene?ts, as Well as better 
storage properties. LikeWise, there is a need to produce 
animals Whose meat products Would contain glycerolipids 
With fatty acids having different degrees of saturation and/or 
chain length. Such changes improve the ?avor and storage 
properties and reduce adverse effects on humans, for 
eXample, by reducing the percentage of polyunsaturated 
fatty acids. 
BRIEF DESCRIPTION OF DRAWINGS 
FIG. 1 shoWs a restriction map of the SLC1 chromosomal 
locus and plasmid subclones. The location of the SLC1 open 
reading frame is denoted by the open arroW. p411 is plasmid 
YEp434 carrying an 8.5-kb DNA fragment that contains the 
SLC1-1 suppressor allele. Only the insert portion of each 
plasmid is shoWn. Derivatives of p411 carrying a portion of 
the original insert are shoWn as is 411i#3, Which carries an 
unspeci?ed 500-bp Sau3A1 fragment obtained from 
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YEp434 and inserted into the BglII site of p411. The ability 
of plasmids to confer an Lcb+ phenotype on Lcb‘ strain 1A4 
is indicated. pN57 and pN15 are integrating vectors carrying 
the SLC1 gene retrieved from strain 1A4 using pRS305. 
Restriction endonuclease sites are: B, BamHI; B-Sa, 
BamHI-Sau3A1 junction; Bg, BglII; E, EcoRI; H, HindIII; 
Nh, NheI; Ns, NsiI; S, SalI. 
FIG. 2 shoWs the nucleotide sequence of SLC1. ShoWn 
beloW the SLC1 nucleotide sequence (SEQ ID NO:1) is the 
protein sequence. A membrane spanning domain is under 
lined. N-linked glycosylation sites are indicated by brackets, 
and putative N-myristoylation sites are indicated by paren 
theses. A start codon for ORFX is indicated by the CAT 
sequence upstream of the SLC1 start codon. Putative 
inositol/choline response elements upstream of the SLC1 
start codon are double underlined. Nucleotide 131 is 
mutated from an A to a T in the SLC1-1 suppressor allele 
(shoWn in bold). 
FIG. 3 shoWs protein homology. The SLC1 protein 
sequence (SEQ ID NO: 2) Was aligned With the E. coli PlsC 
protein (PLSC) (SEQ ID NO:3) and the S. typhimurium parF 
protein (PARF) (SEQ IS NO:4) using the program 
CLUSTAL (39). Amino acid residues identical in the three 
proteins are indicated by an asterisk beloW the sequence; 
similar residues are indicated by a dot. 
FIG. 4 shoWs SLC1 gene complements E. coli mutant. E. 
coli strain J C201, carrying a temperature-sensitive mutation 
in the plsC gene, Was transformed With the vector pRS315, 
or the vector carrying a 4.15 -kb BamHI fragment containing 
the yeast Wild type SLC1+ gene, or the suppressor allele 
SLC1-1. Colonies of each type of transformant Were 
streaked onto LB plates and tested for groWth at the indi 
cated temperature. The length of incubation in hours is 
indicated. 
FIG. 5 shoWs the chromosomal location of SLC1. A 
restriction map of a portion of the left arm of chromosome 
IV is depicted at the top of the ?gure. The map Was 
constructed by overlapping )» clones carrying S. cerevisiae 
DNA inserts (30). Vertical lines indicate EcoRI or HindIII 
restriction sites used to order and overlap )» clones. Unor 
dered restriction fragments are bound by short vertical lines. 
The alignment of two 9» clones, 3769 and 2328, and the S. 
cerevisiae DNA insert in p411 is shoWn. 
FIGS. 6A—C shoWs an analysis of SLC1 transcription by 
Northern blot hybridiZation. Panel A, each hybridiZation 
reaction included an LYS2 probe as an internal control for 
mRNA concentration. Molecular Weight markers and their 
siZe in kilobases are indicated at the side of the autoradio 
grams. Panel B, as in panel A, but after transfer of the RNA 
to the membrane, the membrane Was divided, and each 
section Was hybridiZed separately With a riboprobe as indi 
cated beloW each lane. Panel C, restriction map of analyZed 
region shoWing the location and 5‘ to 3‘ direction of the 
riboprobes. Open reading frames are shoWn as an open boX. 
The 3‘ end of ORFX has not been determined as indicated by 
the dotted line. The inverted triangle indicates the location of 
the SLC1-1 suppressor mutation. Wavy lines denote the 
deduced locations of the tWo 1.4-kb overlapping transcripts 
described in the teXt. The siZe and orientation of riboprobes 
(PROBES) are indicated. Restriction endonuclease sites are: 
A, AatII; Bg, BglII; E, EcoRI; H, HindIII; Hf, Hin?; Ns, 
Nsil; RV, EcoRV. 
FIGS. 7A—C shoWs construction of an SLC1 deletion 
strain. Panel A, diagram of the slc1A1::URA3 deletion allele 
described under “Experimental Procedures.” Panel B, 
Southern blot analysis of the SLC1 locus in diploid strains 













